ADTRAN Holdings, Inc. Reports Earnings for the Second Quarter of 2022 and Declares Quarterly Cash Dividend

HUNTSVILLE, Ala. — (August 3, 2022) — ADTRAN Holdings, Inc., (NASDAQ: ADTN) (“ADTRAN” or the “Company”), today announced financial results for the second quarter of 2022. For the quarter, revenue was $172.0 million. Net income for the second quarter of 2022 was $2.1 million and earnings per share was $0.04. Non-GAAP net income was $9.7 million and non-GAAP earnings per share was $0.19. Non-GAAP net income and non-GAAP earnings per share exclude stock-based compensation expense, acquisition related expenses, amortizations and adjustments, restructuring expenses, amortization of pension actuarial losses, deferred compensation related adjustments, change in valuation allowance related to our deferred tax assets, and the tax effect of these adjustments to net income. The reconciliations between GAAP net income and earnings per share to non-GAAP net income and non-GAAP earnings per share are set forth in the table provided below.

ADTRAN Chairman and Chief Executive Officer Tom Stanton stated, “We had a strong Q2 fueled by the growing demand for our fiber broadband platforms. Customer demand continues to grow at record levels. We increased revenue both quarter-over-quarter and year-over-year in our domestic and international markets, and also throughout our customer segments. This provides continued momentum as we move forward with our integration of ADVA. The combination of these two companies will strengthen our overall solution portfolio and provide the resources necessary to maximize our success in this unprecedented investment cycle in fiber networks.”

The Company also announced that its Board of Directors declared a cash dividend for the second quarter of 2022. The quarterly cash dividend of $0.09 per common share is to be paid to the Company’s stockholders of record as of the close of business on August 18, 2022. The ex-dividend date is August 17, 2022 and the payment date will be September 1, 2022.

The Company confirmed that it will hold a conference call to discuss its second quarter results on Thursday, August 4, 2022, at 9:30 a.m. Central Time. ADTRAN will webcast this conference call. To listen, simply visit ADTRAN’s Investor Relations site at www.adtran.com/investor approximately ten minutes prior to the start of the call, click on the event “ADTRAN Holdings Releases 2nd Quarter 2022 Financial Results and Earnings Call”, and click on the Webcast link.

An online replay of the Company’s conference call, as well as the text of the Company's conference call, will be available on the Investor Relations site approximately 24 hours following the call and will remain available for at least 12 months. For more information, visit www.investors.adtran.com or email at [email protected].

About ADTRAN Holdings, Inc.

ADTRAN Holdings, Inc. solely owns ADTRAN, Inc. (Adtran) and is the majority shareholder of ADVA Optical Networking SE (ADVA).  Adtran is a leading global provider of open, disaggregated networking and communications solutions. ADVA is a global optical networking solutions provider focused on cloud interconnect, cloud access and network synchronization. The combined technology portfolio can best address current and future requirements, especially regarding the convergence of solutions at the network edge. Learn more on Adtran.com, LinkedIn, and Twitter.

Unless the context otherwise indicates or requires, references in this press release and the accompanying financial information to  “ADTRAN,” the “Company,” “we,” “us” and “our” refer to (i) ADTRAN, Inc. and its consolidated affiliates prior to the merger on July 8, 2022 of Acorn MergeCo, Inc. (“Merger Sub”), a Delaware corporation and wholly-owned direct subsidiary of ADTRAN Holdings, Inc. (f/k/a Acorn HoldCo), with and into ADTRAN, Inc., as part of ADTRAN’s business combination transaction with ADVA, and (ii) ADTRAN Holdings, Inc. and its consolidated subsidiaries following the Merger. 

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, generally identified by the use of words such as “believe,” “expect,” “intend,” “estimate,” “anticipate,” “will,” “may,” “could” and similar expressions, which forward-looking statements reflect management’s best judgment based on factors currently known. However, these statements involve risks and uncertainties, including: (i) risks and uncertainties related to the continued impact of the SARS-CoV-2 coronavirus/COVID-19 global pandemic (including variants of the SARS-CoV-2 coronavirus), including with respect to continued manufacturing and supply chain constraints; (ii) regulatory or other limitations imposed following the closing of the Company’s business combination with ADVA on July 15, 2022; the success of the combined ADTRAN and ADVA businesses following the business combination; the ability to successfully integrate the ADTRAN and ADVA businesses; risks related to disruption of management time from ongoing business operations due to integration efforts following the business combination; the risk that the publicity surrounding the business combination could have adverse effects on the market price of ADTRAN’s common stock or ADVA’s common shares or the ability of ADTRAN and ADVA to retain customers, retain or hire key personnel, maintain relationships with their respective suppliers and customers, and on their operating results and businesses generally; the risk that ADTRAN Holdings may be unable to achieve expected synergies or that it may take longer or be more costly than expected to achieve those synergies; the risk of fluctuations in revenue due to lengthy sales and approval process required by major and other service providers for new products; the risk posed by potential breaches of information systems and cyber-attacks; the risks that ADTRAN, ADVA or ADTRAN Holdings may not be able to effectively compete, including through product improvements and development, and (iii) the other risks set forth in ADVA’s annual and interim financial reports made publicly available and ADTRAN’s and ADTRAN Holdings’ public filings made with the Securities and Exchange Commission, including ADTRAN’s Annual Report on Form 10-K for the year ended December 31, 2021 and ADTRAN’s Form 10-Q for the quarterly period ended March 31, 2022. These risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements included in this press release.

To provide additional transparency, we have disclosed in the tables below non-GAAP operating income, which has been reconciled to operating income, and non-GAAP net income and non-GAAP earnings per share - basic and diluted, which have been reconciled to net income and earnings per share - basic and diluted, in each case as reported based on Generally Accepted Accounting Principles in the United States (“U.S. GAAP”). These non-GAAP financial measures exclude certain items which management believes are not reflective of the ongoing operating performance of the business. We believe this information is useful in providing period-to-period comparisons of the results of our ongoing operations. Additionally, these measures are used by management in our ongoing planning and annual budgeting processes. We believe the presentation of non-GAAP operating income, non-GAAP net income and non-GAAP earnings per share - basic and diluted, when combined with the U.S. GAAP presentation of operating income, net income and earnings per share - basic and diluted, is beneficial to the overall understanding of ongoing operating performance of the Company.

These non-GAAP financial measures are not prepared in accordance with, or an alternative for, U.S. GAAP and therefore should not be considered in isolation or as a substitution for analysis of our results as reported under U.S. GAAP. Additionally, our calculation of non-GAAP operating income, non-GAAP net income and non-GAAP earnings per share - basic and diluted, may not be comparable to similar measures calculated by other companies.

Investor Services/Assistance:

Rhonda Lambert/256-963-7450

[email protected] 

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

Condensed Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data)

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

Supplemental Information

Reconciliation of Operating Income to Non-GAAP Operating Income

(Unaudited)

(Amounts in table in thousands)

⁽¹⁾ $1.6 million is included in selling, general and administrative expenses and $0.5 million is included in research and development expenses on the condensed consolidated statements of income.                           

⁽²⁾ $0.2 million is included in total cost of revenue, $1.1 million is included in selling, general and administrative expenses and $0.6 million is included in research and development expenses on the condensed consolidated statements of income.                                                                                                 
⁽³⁾ Includes non-cash change in fair value of equity investments held in the ADTRAN, Inc. Deferred Compensation Program for Employees, all of which is included in selling, general and administrative expenses on the condensed consolidated statement of income.                                                                                   
⁽⁴⁾ $1.9 million is included in selling, general and administrative expenses and $0.5 million is included in research and development expenses on the condensed consolidated statements of income.                           

⁽⁵⁾ $0.1 million is included in total cost of revenue, $1.1 million is included in selling, general and administrative expenses and $0.6 million is included in research and development expenses on the condensed consolidated statements of income.                                                       
 

⁽⁶⁾ Less than $0.1 million is included in selling, general and administrative expenses and research and development expenses on the condensed consolidated statements of income.                                                       
 

⁽⁷⁾ $3.5 million is included in selling, general and administrative expenses and $1.0 million is included in research and development expenses on the condensed consolidated statements of income.             
 

⁽⁸⁾ $0.3 million is included in total cost of revenue, $2.3 million is included in selling, general and administrative expenses and $1.2 million is included in research and development expenses on the condensed consolidated statements of income.                                                                                                 
⁽⁹⁾ Less than $0.1 million is included in selling, general and administrative expenses on the condensed consolidated statements of income.                                                                                                               
⁽¹⁰⁾ $2.4 million is included in selling, general and administrative expenses and $1.0 million is included in research and development expenses on the condensed consolidated statements of income.             
 

⁽¹¹⁾ $0.2 million is included in total cost of revenue, $2.2 million is included in selling, general and administrative expenses and $1.2 million is included in research and development expenses on the condensed consolidated statements of income.                                                                                                 
⁽¹²⁾ $0.1 million is included in selling, general and administrative expenses and $0.2 million is included in research and development expenses on the condensed consolidated statements of income.                                                                                                                           

 

Supplemental Information

Reconciliation of Net Income and Earnings per Common Share – Basic and Diluted

to Non-GAAP Net Income and Non-GAAP Earnings per Common Share – Basic and Diluted

(Unaudited)

(Amounts in table in thousands, except per share amounts)

		Three Months Ended March 31,									Nine Months ended September 30,
		2022				2021					2021				2020
Net Income		$	2,143			$	5,086				$	1,016			$	5,982
Acquisition-related expenses, amortizations and adjustments			2,123		Die wichtigsten Finanzdaten auf einen Blick   2017 2018 2019 2020 2021 2022 2023 Umsatzerlöse1 556,66 462,36 406,45 356,57 440,45 960,49 960,49 EBITDA1,2 44,30 -25,80 -19,81 5,58 1,22 -4,94 -98,13 EBITDA-Marge3 7,96 -5,58 -4,87 1,56 0,28 -0,51 EBIT1,4 31,21 -39,68 -35,68 -7,95 -12,98 -68,21 -200,46 EBIT-Marge5 5,61 -8,58 -8,78 -2,23 -2,95 -7,10 -20,87 Jahresüberschuss1 19,90 -16,98 -47,31 1,94 -7,62 -8,32 -234,95 Netto-Marge6 3,57 -3,67 -11,64 0,54 -1,73 -0,87 -24,46 Cashflow1,7 -35,37 48,44 -2,21 -13,45 2,67 -41,42 -41,31 Ergebnis je Aktie8 0,49 -0,40 -0,99 0,04 -0,16 -0,03 -3,09 Dividende8 0,26 0,31 0,35 0,35 0,35 0,33 0,34 Quelle: boersengefluester.de und Firmenangaben   Geschäftsbericht 2023 - Kostenfrei herunterladen.   1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de Wirtschaftsprüfer: PricewaterhouseCoopers INVESTOR-INFORMATIONEN ©boersengefluester.de Adtran Holdings WKN Kurs in € Einschätzung Börsenwert in Mio. € A3C7M6 5,674 448,93 KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV 37,83 36,78 0,98 -18,54 KBV KCV KUV EV/EBITDA 0,83 - 0,43 -5,57 Dividende '22 in € Dividende '23 in € Div.-Rendite '23 in % Hauptversammlung 0,33 0,00 0,00 08.05.2024 Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK 09.08.2024 15.03.2024 Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen 17,64% 2,25% -16,41% -38,15%

Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Adtran Holdings, Inc.  ISIN: US00486H1059 können Sie bei EQS abrufen